Breakthrough discovery paves the way for new methods to detect and treat leukemia

Note that some links may require registration or subscription. Haleon issued a voluntary recall of eight lots of Robitussin Honey CF Max Day Adult and

No­var­tis wants in on the work at Arv­inas, one of the ear­ly lead­ers in the pro­tein de­grad­er field that has got­ten in­to Phase 3 with

Ake­bia now ex­pects to re­file its chron­ic kid­ney dis­ease treat­ment vadadu­s­tat by the end of Sep­tem­ber. The biotech said Thurs­day morn­ing that it had a